APOLLO-B Phase 3 Study Results Published in the New England Journal of Medicine

APOLLO-B Phase 3 Study Results Published in the New England Journal of Medicine

Results from the APOLLO-B Phase 3 study of investigational patisiran in patients with the cardiomyopathy of transthyretin-mediated (ATTR) amyloidosis were published in the New England Journal of Medicine.

Read the manuscript



SIGN UP FOR EMAIL UPDATES

Receive news and updates on the work at Alnylam that affects you most.